Yasine Mirmozaffari

Dr. Yasine Mirmozaffari

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2025 in Current Allergy and Asthma Reports
Verified
Journal Article
Closed access
PDF file
WMW. Jared Martin
W. Jared Martin
YMYasine Mirmozaffari
Yasine Mirmozaffari
LCLauren M. Cook
Lauren M. Cook
EBEzer H. Benaim
Ezer H. Benaim
AMAurelia Monk
Aurelia Monk
Adam KimpleAdam Kimple
Adam Kimple

19 June 2025 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
YMYasine Mirmozaffari
Yasine Mirmozaffari
MLMichael Ly
Michael Ly
EBEzer H. Benaim
Ezer H. Benaim
LBLuke O. Barron
Luke O. Barron
MRMeghan Rebuli
Meghan Rebuli
Background: Cytokines are crucial mediators in cell-to-cell communication, immune regulation, and the pathophysiology of rhinologic diseases. Distinguishing cytokine profiles can elucidate inflammation types [eg, T-helper type 1 (Th1), Th2, and Th17] and guide therapeutic options. Various methods for cytokine sampling in the sinonasal cavity exist. This review aimed to provide an in-depth review of these methods, including their advantages, limitations, and analytical techniques. Methods: A narrative literature review was conducted using Medical Subject Headings (MeSH) keywords in PubMed and Google Scholar. Key MeSH terms include “cytokines,” “mucus,” “interleukins,” “biomarkers,” “sinonasal disease,” “chemokines,” “paranasal sinuses,” and “sampling.” Results: There are many different methods of cytokine sampling in the sinonasal cavity. Common methods include nasal lavage, forced exhalation, collection of nasal epithelial lining fluid, nasopharyngeal swab, cytobrush, sponge, suction, and tissue biopsy. Each method used has advantages and limitations, such as type of sample collected, location specificity, invasiveness, sample dilution and volume variability, and utility for downstream analytical assays. Conclusions: Advancements in cytokine sampling and pharmacological targeting in sinonasal disease are instrumental for the diagnosis and management of patients with sinonasal disease. Understanding these methods’ strengths and weaknesses can improve patient care and guide treatment development.

13 August 2025 in The Laryngoscope
Verified
Journal Article
Closed access
YMYasine Mirmozaffari
Yasine Mirmozaffari
WMW. Jared Martin
W. Jared Martin
EBEzer H. Benaim
Ezer H. Benaim
MLMeredith H. LaSpaluto
Meredith H. LaSpaluto
CDChristine E. DeMason
Christine E. DeMason
DLDoris Lin
Doris Lin

18 August 2025 in The Cleft Palate Craniofacial Journal
Verified
Journal Article
Open access
VFVictoria Fonseca
Victoria Fonseca
EQElena Quinonez
Elena Quinonez
PMPhilip McDaniel
Philip McDaniel
YMYasine Mirmozaffari
Yasine Mirmozaffari
LLLauren Leeper
Lauren Leeper
ADAmelia Drake
Amelia Drake
Objective: This study evaluates the impact of travel distance and surgical timing on outcomes in patients undergoing palate surgery. Design: A retrospective cohort study analyzing patient data from electronic medical records. Univariate and Kruskal-Wallis analyses assessed associations between distance, timing, and outcomes. Setting: A single academic, American Cleft Palate Craniofacial Association -approved tertiary craniofacial center in North Carolina. Patients, Participants: One hundred and ninety-eight patients who underwent palate surgery from 2016 to 2023. Exclusion criteria included age >12 years, submucosal clefts, out-of-state residence, and lack of follow up. Interventions: Palate surgery categorized as early (13 months). Main Outcome Measure(s): Age at first craniofacial visit, age at surgery, time between visit and surgery, emergency department (ED) visits within 30 days of surgery, and incidence of velopharyngeal insufficiency (VPI) or speech therapy referral by age 3. Results: Median age at palate surgery was 10.1 months. Increased distance was significantly associated with increased age at clinic presentation ( P = .042) and surgery ( P = .041), but not increased time between first visit and surgery ( P = .811). Earlier surgery was associated with reduced ED visits ( P = .0159) and speech therapy referrals ( P = .0255). VPI incidence was 11.4%, with no significant correlation to timing or distance. Conclusions: Increased travel distance is associated with later primary palate surgery. Addressing geographic disparities is crucial to improving patient outcomes.

23 September 2025 in The Laryngoscope
Verified
Journal Article
Closed access
ZKZane D. Kaiser
Zane D. Kaiser
YMYasine Mirmozaffari
Yasine Mirmozaffari
RBRobert A. Buckmire
Robert A. Buckmire
RSRupali N. Shah
Rupali N. Shah

1 July 2026
Verified
Other
Open access
SVSri Vemulamanda
Sri Vemulamanda
AKAditi Kothari
Aditi Kothari
LCLoris De cecco
Loris De cecco
SKSulgi Kim
Sulgi Kim
AKAditi Kulkarni
Aditi Kulkarni
TSTravis P. Schrank
Travis P. Schrank
Supplemental Figure 3. Boxplot of NF- κB values across the three cluster subtypes. By unsupervised consensus clustering and self-organizing map (SOM) approaches, we identified three distinct biological subtypes within HPV-positive HNSCC: Cl1 (immune-related), Cl2 (epithelial-mesenchymal transition [EMT]-related), and Cl3 (proliferation-related). This classification holds prognostic significance, with Cl1 exhibiting the most favorable survival outcomes, Cl2 associated with the poorest prognosis, and Cl3 displaying an intermediate survival rate [Locati, 2019]. In contrast to recent studies that classified HPV-related HNSCC into immune and keratinocyte subtypes, our analysis confirmed the immune-associated subtype while further resolving the keratinocyte group into two distinct clusters with differing biological profiles and prognostic implications. NF-κB signature is significantly activated in Cl1-immune related cluster compared to the other 2 clusters: A) Metanalyisis-HPV267 cohort (1); B) BD2-HPV286 cohort (2).